It has been proposed that c-Src kinase mediates the nuclear translocation of EGFR, an event that contributes to the acquired resistance to the anti-EGFR antibody cetuximab in colorectal cancer and head and neck squamous cell carcinoma (HNSCC; Figure 1). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.